John Chetwood
johnchetwood.bsky.social
John Chetwood
@johnchetwood.bsky.social
Gastroenterologist. IBD. Clinician researcher.
UC, Crohns, Biologics, next-gen drugs,Trop Med.
Proud girl dad, occasional runner, hiker.
#MedSky #IBD
Reposted by John Chetwood
Deceit, as this study shows, is one way to maximize the placebo effect

doi.org/10.1053/j.ga...

But there is a better way

That way is caring, empathy, and connection - slow down the visit by 1 minute and make a big difference (some evidence in next slide)
March 15, 2025 at 1:10 AM
Reposted by John Chetwood
Prolonged COVID-19 shedding in complicated lung transplant patient - a tricky case for us to navigate at the time! Interested in whether de-isolation policies have since changed at other centres? #IDSky #TxID @alyssapradhan.bsky.social

onlinelibrary.wiley.com/doi/10.5694/...
Prolonged SARS‐CoV‐2 shedding in a lung transplant recipient: time for flexibility in infection prevention?
Click on the article title to read more.
onlinelibrary.wiley.com
December 10, 2024 at 8:24 PM
Interesting and thought provoking article by @bealoquebea.bsky.social on the potential harms of placebo-controlled trials in IBD. But are H2H trials a viable alternative?
Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis
In maintenance of remission trials in IBD, placebo was associated with some clinically significant potential harms. Patients should be counselled about these before participating in clinical trials an...
www.thelancet.com
November 19, 2024 at 12:36 AM
First post and newbie here! Excited to be part of this shindig. Looking to connect to all things #GastroSky#medsky #liversky #Gastroenterology #colitis #crohns
Please feel free to direct and suggest ☺️
November 14, 2024 at 12:55 PM